Royal Devon ranked among UK's best trusts for cancer patient experience


Cancer patients treated by the Royal Devon rated their care 9.1 out of 10 in a major new NHS survey, placing the trust 11th in the country and top of the South West Peninsula.
The Royal Devon University Healthcare NHS Foundation Trust has been ranked among the best performing trusts in the country for cancer patient experience, according to the results of the 2025 National Cancer Patient Experience Survey.
The trust placed 11th equal nationally, level with Mersey and West Lancashire Teaching Hospitals NHS Trust, and came top of the wider South West Peninsula.
A total of 1,525 patients responded to the survey, giving a response rate of 58 per cent, well above the national average of 48 per cent. Patients rated their overall care at an average of 9.1 out of 10, matching the national score.
Of the 59 questions in the survey, the trust scored above the expected range for 35, an increase of 11 compared with the 2024 results. No questions scored below the expected range, meaning the trust did not underperform against its expected benchmark on any measure.
Patients said the trust performed particularly well on giving information about diagnostic tests in advance, protecting their privacy when receiving test results, treating them with respect and dignity in hospital, and ensuring care teams and administrators worked well together to provide support.
The survey data shows 95 per cent of patients said they received all the information they needed about diagnostic tests in advance, against a national score of 92 per cent. Ninety per cent said they were always treated with respect and dignity while in hospital, and 92 per cent said the whole care team worked well together.
The figures also show improvement over time. The proportion of patients who said they were definitely able to have a discussion about their needs or concerns before treatment rose from 74 per cent in 2021 to 79 per cent in 2025, a statistically significant increase. The proportion who felt possible side effects from treatment were properly explained rose from 55 per cent in 2021 to 61 per cent this year.
Carolyn Mills, chief nursing officer at the trust, said the senior cancer team was extremely proud of the results, particularly the increase of 11 questions scoring above the expected average. She said the achievement reflected the continued dedication of the trust's multidisciplinary teams and their efforts every day to provide the best possible care for patients.
The results will be reviewed alongside further qualitative feedback from patients and national benchmarking data, with plans drawn up to address areas identified for improvement.
This year's survey was the fifteenth National Cancer Patient Experience Survey, first introduced in 2010. It is designed to monitor progress on cancer care, inform local quality improvements, and support commissioners, providers and charities working with cancer patients.
It is sent to adult NHS patients with a confirmed primary diagnosis of cancer who were discharged from an NHS trust following an inpatient episode or day case attendance for cancer-related treatment between April and June 2025. Fieldwork ran between November 2025 and February 2026. Nationally, 134,285 patients were sent the survey and 64,268 responded.
The survey was carried out by the research organisation Picker on behalf of NHS England.